Medical News

RSS

Conmed first quarter net revenue increases 16.1% to $18.9 million

Conmed Healthcare Management, Inc. today announced financial results for its first quarter ended March 31, 2012.

15 May 2012

CHDI, KineMed partner to investigate turnover rates of huntingtin protein

KineMed, Inc. and CHDI Foundation, Inc. announced today a collaboration to use KineMed's isotopic labeling and dynamic proteomics platform to investigate the turnover rates of huntingtin protein, a mutant form of which plays a central role in the pathogenesis of Huntington's disease (HD).

15 May 2012

Narrower CRAE may increase risk of CVD among African Americans with type 1 diabetes

Among African Americans with type 1 diabetes mellitus, narrower central retinal arteriolar equivalent (average diameter of the small arteries in the retina) is associated with an increased risk of six-year incidence of any cardiovascular disease and lower extremity arterial disease, according to a report in the May issue of Archives of Ophthalmology, a JAMA Network publication.

15 May 2012

Women more likely to have different set of sports injuries than men

With the predominance of male athletes featured on television and covered in the media year-round, most Americans are familiar with some of the most common injuries sustained by men in various sports. As the 2012 Summer Games approaches, female athletes will have additional opportunities to be featured, but are their potential injury risks the same as their male counterparts?

15 May 2012

CooperVision to launch Proclear 1 day multifocal lenses

More than one billion people worldwide have a vision condition called presbyopia(1), which is a natural decrease in the ability of the lens in the eye to change its shape to focus on close objects. We've all seen others struggle with trying to read menus and newspapers. Maybe it has even happened to you.

15 May 2012

PDI first quarter revenue decreases 28% to $31.7 million

PDI, Inc., today reported financial and operational results for the first quarter ended March 31, 2012.

15 May 2012

Cubist announces results from CB-5945 Phase 2 studies on chronic non-cancer pain, OIC

Cubist Pharmaceuticals, Inc. today announced that the results from the Phase 2 studies of CB-5945 (formerly ADL5945) in patients with chronic non-cancer pain and opioid-induced constipation (OIC) will be presented at the 31st Annual Scientific Meeting of the American Pain Society taking place May 16 to 19, 2012, in Honolulu and during Digestive Disease Week 2012 taking place May 19 to 22, 2012, in San Diego.

15 May 2012

Five new capabilities added to Aetna Rx Check Program

Aetna today announced that it is adding five new capabilities to Aetna Rx Check, a collection of programs designed to promote safety and prevent the misuse of various prescription drugs such as pain medications and antibiotics.

15 May 2012

More than one in seven U.S. seniors faces threat of hunger

A new study that looked at the hunger trends over a 10-year period found that 14.85 percent of seniors in the United States, more than one in seven, face the threat of hunger. This translates into 8.3 million seniors.

15 May 2012

First study to examine pediatric injuries linked with pacifiers, bottles and sippy cups

A new study by researchers in the Center for Biobehavioral Health and the Center for Injury Research and Policy at Nationwide Children's Hospital examined pediatric injuries associated with baby bottles, pacifiers and sippy cups.

15 May 2012

OPKO receives U.S. patent allowance titled, ‘Flow Control in Microfluidic Systems’

OPKO Health, Inc. today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled "Flow Control in Microfluidic Systems".

15 May 2012

Researchers identify new biomarker and therapeutic target for pancreatic cancer

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper will be published May 15 in Cancer Research.

15 May 2012

Helico reaches patent litigation settlement with Pacific Biosciences

Helicos BioSciences Corporation announced today that it has settled its patent infringement litigation against Pacific Biosciences, Inc.

15 May 2012

Latest statistics: Cancer deaths in 50-59 year olds have dropped to 14,000

The number of people in their 50s dying prematurely from cancer in the UK has fallen below 14,000 for the first time in 40 years according to new Cancer Research UK figures published today.

15 May 2012

Biogen Idec announces availability of two new AVONEX dosing innovations for MS

Biogen Idec announced that two new dosing innovations designed to help patients receiving once-a-week AVONEX (interferon beta-1a) for relapsing forms of multiple sclerosis (MS) are now available in U.S. pharmacies.

15 May 2012

OIC introduces Pedicle Screw System

The Orthopaedic Implant Company (OIC) has announced the launch of its Pedicle Screw System. The new product line is used for stabilization and fixation during posterior spinal fusion procedures.

15 May 2012

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE Health, Inc. today reported financial results for the three months ended March 31, 2012 and provided a business update.

15 May 2012

Humana, KaBOOM! partner to build multi-generational playground at Tampa

Humana Inc. is teaming up with the City of Tampa, VM Ybor Neighborhood Association, and KaBOOM! to build a one-of-a-kind, multi-generational playground at Tampa's Ragan Park.

15 May 2012

CU scientist looks at reward circuits in the brain

Why does one person become anorexic and another obese? A study recently published by a University of Colorado School of Medicine researcher shows that reward circuits in the brain are sensitized in anorexic women and desensitized in obese women.

15 May 2012

Pearl Therapeutics to present PT003 Phase 2b study on COPD at ATS meeting

Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.

15 May 2012